Knuff & Co’s Idexx Laboratories IDXX Stock Holding History

Knuff & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$66K	–	146
2021 Q4	$66K	Hold	100	–	–	0.02%	114
2021 Q3	$62K	Hold	100	–	–	0.02%	110
2021 Q2	$63K	Buy	+100	New	+$55.2K	0.02%	113

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Knuff & Co's IDXX Position: Q1 2022 in Review

Knuff & Co sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 100 shares — an estimated $66K sold.

Knuff & Co first reported a position in IDXX in Q2 2021 and held it in 3 quarters. The position peaked at $66K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Knuff & Co reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Knuff & Co sold 100 Idexx Laboratories shares in Q1 2022, an estimated $66K.
Knuff & Co first reported a position in Idexx Laboratories in Q2 2021 and held it in 3 quarters.
Knuff & Co's Idexx Laboratories position peaked at $66K in Q4 2021.
1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Knuff & Co's 13F filing for Q1 2022, filed 10 May 2022.